Pulse Biosciences Stock In The News

PLSE Stock  USD 19.63  1.84  10.34%   
Our overall analysis of Pulse Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Pulse Biosciences. The specific impact of Pulse Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pulse Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pulse Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pulse Biosciences Backtesting and Pulse Biosciences Hype Analysis.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

Pulse Biosciences Today Top News and Investor Outlook

Yahoo News
Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchases
https://finance.yahoo.com/news/insiders-pulse-biosciences-inc-nasdaq-140102169.html
 Bullish
Yahoo News
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
https://finance.yahoo.com/news/pulse-biosciences-files-510-k-130000323.html
 Bullish
Yahoo News
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFXâ„¢ Nanosecond Pulsed Field Ablation (nsPFAâ„¢) Cardiac Catheter
https://finance.yahoo.com/news/pulse-biosciences-announces-first-human-130000372.html
 Bullish
Yahoo News
Executive Chairman of Pulse Biosciences Robert Duggan Buys More Stock
https://finance.yahoo.com/news/executive-chairman-pulse-biosciences-robert-120939645.html
 Bullish
Yahoo News
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
https://finance.yahoo.com/news/pulse-biosciences-files-510-k-130000063.html
 Bullish
Yahoo News
Chief Strategy Officer of Pulse Biosciences Picks Up 24% More Stock
https://finance.yahoo.com/news/chief-strategy-officer-pulse-biosciences-121139815.html
 Bullish
Yahoo News
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
https://finance.yahoo.com/news/pulse-biosciences-present-35th-annual-210500299.html
 Bullish
Yahoo News
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Call Transcript
https://finance.yahoo.com/news/pulse-biosciences-inc-nasdaq-plse-175238253.html
 Bullish
Yahoo News
Q3 2023 Pulse Biosciences Inc Earnings Call
https://finance.yahoo.com/news/q3-2023-pulse-biosciences-inc-071546763.html
 Bullish
Yahoo News
Pulse Biosciences Inc (PLSE) Reports Decrease in Q3 Losses and Advances in Cardiac Device ...
https://finance.yahoo.com/news/pulse-biosciences-inc-plse-reports-161309577.html
 Neutral

Pulse Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pulse and other traded companies coverage with news coverage. We help investors stay connected with Pulse headlines for the 4th of January to make an informed investment decision based on correlating the impacts of news items on Pulse Stock performance. Please note that trading solely based on the Pulse Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pulse Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pulse Biosciences investors visualize upcoming and past events in order to time the market based on Pulse Biosciences noise-free hype analysis.
Pulse Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pulse earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pulse Biosciences that are available to investors today. That information is available publicly through Pulse media outlets and privately through word of mouth or via Pulse internal channels. However, regardless of the origin, that massive amount of Pulse data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulse Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulse Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulse Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulse Biosciences alpha.

Pulse Largest EPS Surprises

Earnings surprises can significantly impact Pulse Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-13
2023-09-30-0.22-0.190.0313 
2023-05-11
2023-03-31-0.22-0.26-0.0418 
2022-08-10
2022-06-30-0.4-0.44-0.0410 
2019-04-30
2019-03-31-0.44-0.49-0.0511 
2024-05-07
2024-03-31-0.24-0.18370.056323 
2022-05-11
2022-03-31-0.52-0.58-0.0611 
View All Earnings Estimates

Pulse Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pulse Biosciences Stock. The global stock market is bullish. About 62% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
19th of December 2024
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
at finance.yahoo.com 
Yahoo News
17th of December 2024
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surg...
at finance.yahoo.com 
Yahoo News
16th of December 2024
Robert Duggan Spends US972k On Pulse Biosciences Stock
at finance.yahoo.com 
news
12th of December 2024
Pulse Biosciences Trading Down 5.4 percent Should You Sell
at thelincolnianonline.com 
Investing News at Macroaxis
6th of December 2024
Pulse Biosciences announces CEO departure and interim leadership
at investing.com 
Simply Wall St News at Macroaxis
15th of November 2024
Pulse Biosciences, Inc.s largest shareholder, Top Key Executive Robert Duggan sees holding...
at simplywall.st 
Macroaxis News
5th of November 2024
Acquisition by Zanganeh Mahkam of 200000 shares of Pulse Biosciences at 15.65 subject to R...
at MacroaxisInsider 
Gurufocus Stories at Macroaxis
31st of October 2024
Pulse Biosciences Inc Q3 2024 Earnings Call Highlights Strategic Advances Amid ...
at gurufocus.com 
businesswire News
30th of October 2024
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
at businesswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pulse Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pulse Biosciences' short interest history, or implied volatility extrapolated from Pulse Biosciences options trading.
When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:
Check out Pulse Biosciences Backtesting and Pulse Biosciences Hype Analysis.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.82)
Return On Assets
(0.38)
Return On Equity
(0.70)
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.